MediLogos

Company Overview

Snapshot

Founded in January 2011 by Eran Ayzik, Erez Shalom, and Yuval Shahar, MediLogos operates with 1–10 employees. The company has raised $1.6 million across two funding rounds. MediLogos ceased to operate in June 2019.

Business overview

MediLogos developed a medical care platform that integrates patient data and clinical knowledge in real time to provide clinical decision support and data analysis. This platform aims to resolve physicians' cognitive overload, enable analysis of single- and multiple-patient data, and offer evidence-based recommendations and long-term monitoring capabilities. The company also developed Guideline-Driven and Intelligent Monitoring (GLAMOR) for chronic disease management and MobiGuide, a mobile solution for patient guidance based on clinical guidelines and personal health records. MediLogos operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving healthcare providers and the pharmaceutical industry globally, including in Israel and Canada.

Company Intelligence Q&A

What is the primary focus of MediLogos' technology?

MediLogos focuses on clinical decision support and data analysis, providing a medical care platform that integrates patient data and clinical knowledge in real time to assist physicians and improve healthcare outcomes.

When was MediLogos founded and by whom?

MediLogos was founded in January 2011 by Eran Ayzik, Erez Shalom, and Yuval Shahar.

What is the status of MediLogos?

MediLogos ceased to operate in June 2019.

Which product is designed for chronic disease management?

MediLogos developed Guideline-Driven and Intelligent Monitoring (GLAMOR), an application designed to improve healthcare outcomes for patients with chronic diseases.

What was the total capital raised by MediLogos?

MediLogos raised a total of $1.6 million across two funding rounds.